Susquehanna International Group’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5445 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5360 |
|
|
2018
Q2 | – | Sell |
-499,801
| Closed | -$4.54M | – | 5295 |
|
|
2018
Q1 | $4.54M | Buy |
499,801
+481,852
| +2,685% | +$4.38M | ﹤0.01% | 543 |
|
|
2017
Q4 | $77K | Sell |
17,949
-28,867
| -62% | -$124K | ﹤0.01% | 3375 |
|
|
2017
Q3 | $66K | Sell |
46,816
-86,590
| -65% | -$122K | ﹤0.01% | 2941 |
|
|
2017
Q2 | $200K | Buy |
133,406
+85,864
| +181% | +$129K | ﹤0.01% | 3077 |
|
|
2017
Q1 | $122K | Sell |
47,542
-68,515
| -59% | -$176K | ﹤0.01% | 2950 |
|
|
2016
Q4 | $296K | Buy |
116,057
+93,120
| +406% | +$238K | ﹤0.01% | 3427 |
|
|
2016
Q3 | $71K | Buy |
22,937
+6,226
| +37% | +$19.3K | ﹤0.01% | 2743 |
|
|
2016
Q2 | $54K | Sell |
16,711
-5,260
| -24% | -$17K | ﹤0.01% | 2995 |
|
|
2016
Q1 | $68K | Sell |
21,971
-5,560
| -20% | -$17.2K | ﹤0.01% | 3612 |
|
|
2015
Q4 | $110K | Sell |
27,531
-32,756
| -54% | -$131K | ﹤0.01% | 3932 |
|
|
2015
Q3 | $276K | Buy |
60,287
+35,558
| +144% | +$163K | ﹤0.01% | 3574 |
|
|
2015
Q2 | $128K | Sell |
24,729
-162,680
| -87% | -$842K | ﹤0.01% | 4211 |
|
|
2015
Q1 | $1.17M | Sell |
187,409
-159,581
| -46% | -$999K | ﹤0.01% | 2268 |
|
|
2014
Q4 | $2.18M | Buy |
346,990
+83,242
| +32% | +$524K | ﹤0.01% | 1781 |
|
|
2014
Q3 | $1.6M | Buy |
263,748
+210,040
| +391% | +$1.28M | ﹤0.01% | 1909 |
|
|
2014
Q2 | $353K | Sell |
53,708
-6,177
| -10% | -$40.6K | ﹤0.01% | 3421 |
|
|
2014
Q1 | $1.43M | Buy |
+59,885
| New | +$1.43M | ﹤0.01% | 1791 |
|
|
2013
Q4 | – | Sell |
-26,158
| Closed | -$349K | – | 4339 |
|
|
2013
Q3 | $349K | Buy |
26,158
+14,393
| +122% | +$192K | ﹤0.01% | 2837 |
|
|
2013
Q2 | $154K | Buy |
+11,765
| New | +$154K | ﹤0.01% | 3260 |
|